Skip to content

4Accepted Oct 19, 5:30 PM ET

HealthEquity, Inc.: EVP prod & strat officer Sunil sold/bought 262 shares

HQYHEALTHEQUITY, INC.

Accepted (ET)

5:30 PM

Oct 19, 2026

Filed

Oct 19, 2026

Documents

1

Size

10.8 KB

Summary

HealthEquity, Inc.: EVP prod & strat officer Sunil sold/bought 262 shares

Updated

What happened

  • Rajasekar Sunil, EVP chief prod & strat officer, reported both sales and purchases of HealthEquity, Inc. common stock.
  • Sales: 23 shares on Apr 22, 2026 at $82.81 for $1,905; 108 shares on Aug 24, 2026 at $105.60 for $11,405 (total sold 131 shares for $13,310).
  • Purchases: 23 shares on Jul 8, 2026 at $95.06 for $2,186; 108 shares on Oct 15, 2026 at $90.33 for $9,756 (total bought 131 shares for $11,942).

Key details

  • Transaction dates and prices:
    • Apr 22, 2026 — sale 23 shares @ $82.81 for $1,905.
    • Jul 8, 2026 — purchase 23 shares @ $95.06 for $2,186.
    • Aug 24, 2026 — sale 108 shares @ $105.60 for $11,405.
    • Oct 15, 2026 — purchase 108 shares @ $90.33 for $9,756.
  • Shares owned after the transactions: not stated in the filing excerpt provided.
  • Footnotes:
    • F1 indicates some reported sales were short sales.
    • F4 indicates some purchases represent shares delivered to cover previous short sales.
    • F2 states transactions were executed in broker-managed discretionary accounts without the reporting person's knowledge and that reporting was untimely for that reason.
    • F3 states the reporting person voluntarily paid approximately $1,650 to the issuer as all profits under Section 16(b) arising from these transactions.
  • Timeliness: the filing notes the reporting was untimely (see F2).

Why it may matter

  • The filing shows market sales and purchases and indicates short-sale activity and subsequent cover transactions.
  • The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing